Abstract
Taurine, a β free amino-acid, takes various biological functions including maintain the normal hepatic structure and function. In this study, the regulation mechanism of taurine on lipopolysaccharide (LPS) induced activation of Kupffer cells (KC) in the liver of rats with alcoholic liver disease (ALD) were explored. Male wistar rats were intragastrically administered with alcohol and pyrazole, and ate high-fat diet in order to establish ALD model. Taurine were administered in drinking water simultaneous with and after ALD model establishment. The preventive trial was lasted for 12 weeks, while the curative trial was lasted for 4 weeks. Finally, blood and liver were collected in order to detect the concentrations of plasma LPS and hepatic tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6). Hepatic total RNA were extracted, gene expressions of LPS binding protein (LBP), leukocyte differentiation antigen 14 (CD14), toll-like receptors (TLR4), nuclear transcription factor (NF-κB) and TNF-α were detected by semi-quantitative RT-PCR. The results showed significant elevated levels of plasma LPS, hepatic TNF-α, IL-1β and IL-6 in ALD rats (P < 0.05), and heightened gene expressions of LBP, CD14, TLR4, NF-κB and TNF-α (P < 0.05); Taurine no matter administered preventively or curatively can reduce the levels of plasma LPS, hepatic TNF-α, IL-1β, IL-6, and down-regulate the gene expressions of LBP, CD14, TLR4, NF-κB and TNF-α. The results demonstrated that taurine can prevent and cure ALD by reducing the production and transformation of LPS as well as inhibiting the opening and the transmission of LPS induced KC activation and the downstream signaling pathway.
$These authors have contributed equally to this work.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ALD:
-
Alcoholic liver disease
- CD14:
-
Leukocyte differentiation antigen 14
- IL-1β:
-
Interleukin-1β
- IL-6:
-
Interleukin-6
- LBP:
-
LPS binding protein
- LPS:
-
Lipopolysaccharide
- NF-κB:
-
Nuclear transcription factor
- TLR4:
-
Toll-like receptors
- TNF-α:
-
Tumor necrosis factor alpha
References
Bavia L, de Castro IA, Cogliati B, Dettoni JB, Alves VAF, Isaac L (2016) Complement C5 controls liver lipid profile, promotes liver homeostasis and inflammation in C57BL/6 genetic background. Immunobiology 221:822–832
Elamin EE, Masclee AA, Dekker J, Jonkers DM (2013) Ethanol metabolism and its effects on the intestinal epithelial barrier. Nutr Rev 71:483–499
Forsyth CB, Voigt RM, Burgess HJ, Swanson GR, Keshavarzian A (2014) Circadian rhythms, alcohol and gut interactions. Alcohol 49:389–398
Hartmann P, Chen WC, Schnabl B (2012) The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol 3:402
Hong M, Kim SW, Han SH, Kim DJ, Suk KT, Kim YS, Kim MJ, Kim MY, Baik SK, Ham YL (2015) Probiotics (Lactobacillus rhamnosus R0011 and acidophilus R0052) reduce the expression of toll-like receptor 4 in mice with alcoholic liver disease. PLoS One 10:e0117451
Hsieh YL, Yeh YH, Lee YT, Huang CY (2014) Effect of taurine in chronic alcoholic patients. Food Funct 5:1529–2535
Inokuchi S, Tsukamoto H, Park E, Liu ZX, Brenner DA, Seki E (2011) Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 35:1509–1518
Lin CJ, Chiu CC, Chen YC, Chen ML, Hsu TC, Tzang BS (2015) Taurine attenuates hepatic inflammation in chronic alcohol-fed rats through inhibition of TLR4/MyD88 signaling. J Med Food 18:1291–1298
McClain C, Barve S, Joshi-Barve S, Song Z, Deaciuc I, Chen T, Hill D (2005) Dysregulated cytokine metabolism altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcohol Clin Exp Res 29:1805–1885
Miyazaki T, Matsuzaki Y (2014) Taurine and liver diseases: a focus on the heterogeneous protective properties of taurine. Amino Acids 46:101–110
Nezi V, Deutsch M, Gazouli M, Alexopoulou A, Paparrigopoulos T, Liappas IA, Dourakis SP (2013) Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in greek patients. Alcohol Clin Exp Res 37:244–251
Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C (2000) Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol 32:742–747
Petrasek J, Csak T, Szabo G (2013) Toll-like receptors in liver disease. Adv Clin Chem 59:155–201
Petrasek J, Iracheta-Vellve A, Saha B, Satishchandran A, Kodys K, Fitzgerald KA, Kurt-Jones EA, Szabo G (2015) Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J Leukocyte Biol 98:249–256
Rao R (2009) Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50:638–644
Schaffer SW, Ito T, Azuma J (2014) Clinical significance of taurine. Amino Acids 46:1–5
Schwartz JM, Reinus JF (2012) Prevalence and natural history of alcoholic liver disease. Clin Liver Dis 16:659–666
Song M, Chen T, Prough RA, Cave MC, McClain CJ (2016) Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response. Alcohol Clin Exp Res 40:518–528
Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, Ludwiczek O, Shawcross D, Zoller H, Alisa A, Mookerjee RP, Graziadei I, Datz C, Trauner M, Schuppan D, Obrist P, Vogel W, Williams R (2003) Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 38:419–425
Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gäbele E, Isayama F, Thurman RG (2002) Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 168:2963–2969
Wu GF, Yang JC, Sun CM, Luan XH, Shi J, Hu JM (2009) Effect of taurine on alcoholic liver disease in rats. Amino Acids 36:457–464
Wu T, Liu T, Zhang L, Xing LJ, Zheng PY, Ji G (2014) Chinese medicinal formula, Qinggan Huoxue Recipe protects rats from alcoholic liver disease via the lipopolysaccharide-Kupffer cell signal conduction pathway. Exp Ther Med 8:363–370
Wu GF, Tang RY, Yang JC, Tao Y, Liu ZY, Feng Y, Lin SM, Yang QH, Lv QF, Hu JM (2015) Taurine accelerates alcohol and fat metabolism of rats with alcoholic fatty liver disease. Adv Exp Med Biol 803:793–805
Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, Goyert SM, Thurman RG (2001) Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 166:4737–4742
Yu H, Guo Z, Shen S, Shan W (2016) Effects of taurine on gut microbiota and metabolism in mice. Amino Acids 48:1601–1617
Acknowledgments
This work was supported by the National Natural Science Foundation of China (No. 31302051 and 31172285) and Cultivation Plan for Youth Agricultural Science and Technology Innovative Talents of Liaoning Province (No. 2014049).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this paper
Cite this paper
Wu, G. et al. (2017). Taurine Inhibits Kupffer Cells Activation Induced by Lipopolysaccharide in Alcoholic Liver Damaged Rats. In: Lee, DH., Schaffer, S.W., Park, E., Kim, H.W. (eds) Taurine 10. Advances in Experimental Medicine and Biology, vol 975. Springer, Dordrecht. https://doi.org/10.1007/978-94-024-1079-2_61
Download citation
DOI: https://doi.org/10.1007/978-94-024-1079-2_61
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-024-1077-8
Online ISBN: 978-94-024-1079-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)